From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 ...

Thalassemia remains a pressing health issue in India, with the country bearing a significant burden of this hereditary disorder. Despite advancements in treatment, the condition continues to ...

An Iranian court ruled that the US government and authorities should pay $12,615 million in compensation for the physical and ...

Will consider increasing pension and extending it to all thalassemia patients, says Andhra Pradesh Health Minister Satya ...

India is known as the “Thalassemia capital of the world.” It has the highest number of patients with thalassemia major in the world. India has around 50 million (5 crore) carriers of the ß ...

Health Minister Satyakumar Yadav has said the government is committed to providing comprehensive support to thalassemia ...

Dr. Qidwai earned a 2025 Global Recognition Award for creating Pakistan's first specialized blood disorder facilities. His ...

An Iranian court has ruled US must pay for damages inflicted on thalassemia patients after it deprived them of access to ...

The Rutgers Cancer Institute recently became a designated gene therapy treatment center for sickle cell anemia and beta-thalassemia, joining a small group of medical centers that currently provide ...

Japan's Ono Pharmaceutical is handing over $280 million upfront to acquire Ionis Pharmaceuticals’ phase 2-stage antisense ...

Union Minister Nitin Gadkari commended the Smrutishesh Madhukarrao Tamgadge Charitable Trust, led by IPS officer Sandeep ...